During the past decade, CH de Villefranche - Pneumologie conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 3 clinical trials were completed, i.e. on average, 8.1% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 1 clinical trials were completed. i.e. 5.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH de Villefranche - Pneumologie" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 16 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Hospices Civils de Lyon" with 5 trials sponsored, "Centre Leon Berard" with 3 trials sponsored and "University Hospital, Limoges" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH de Villefranche - Pneumologie" #1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Federation of Medical Specialties" with 2 trials as a collaborator, "Groupe Français de Pneumo-Cancérologie" with 2 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 74 trials.

According to Clinical.Site data, the most researched conditions in "CH de Villefranche - Pneumologie" are "Non Small Cell Lung Cancer" (4 trials), "Non-Small Cell Lung Cancer" (4 trials), "Non-small Cell Lung Cancer" (4 trials), "Non Small Cell Lung Cancer Metastatic" (3 trials) and "Advanced Non Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "CH de Villefranche - Pneumologie" in a lesser frequency.

Most popular intervention types in "CH de Villefranche - Pneumologie" are "Drug" (28 trials), "Other" (8 trials), "Device" (7 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pemetrexed" (5 trials), "Bevacizumab" (4 trials), "Docetaxel" (4 trials), "Gemcitabine" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "CH de Villefranche - Pneumologie" are 55 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "CH de Villefranche - Pneumologie". 1 are not yet recruiting, 14 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in CH de Villefranche - Pneumologie, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CH de Villefranche - Pneumologie, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 12 trials that are defined as “Not Applicable".